Manufacturing “Hub-and-spoke” drug manufacturing set to benefit from new FDA rule Pharmaceutical TechnologyThe proposed rule would allow multiple manufacturing units at different locations to register as one establishment.Read full story pharminent July 13, 2026 (Last updated: July 15, 2026) Pharmaceutical Technology The proposed rule would allow multiple manufacturing units at different locations to register as one establishment. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: FDA approves MSD’s Keytruda combinations for MIBCNext: FDA posts new rejection letters days after confirming pause Related Stories Manufacturing Cellares and Sonoma partner to automate cell therapy manufacturing pharminent July 14, 2026 Manufacturing FDA Warning Letter Hits Sanofi’s Genzyme Ireland Site pharminent July 8, 2026 Manufacturing Tanabe pens deal to sell plants to Towa in post-buyout pivot pharminent July 8, 2026
